Stephen Marcus

Stephen Marcus

Company: Cantex Pharmaceuticals

Job title: ceo


Delving into a Clinical Update on Azeliragon for GBM- Implementable Lessons for Small Molecule Success 11:30 am

In animal models of glioblastoma, azeliragon combined with radiation enhanced survival while overcoming the immunosuppressive tumor microenvironment Two phase II clinical trials of azeliragon, in combination with radiation with or without temozolomide, in newly diagnosed glioblastoma are in progress The effect of azeliragon on cerebral edema and ability to reduce dexamethasone dosing will be evaluated…Read more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.